Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.

International journal of clinical oncology - 1 Nov 2023

Kitazawa Shoko, Chiyoda Tatsuyuki, Nakamura Kohei, Sakai Kensuke, Yoshihama Tomoko, Nishio Hiroshi, Kobayashi Yusuke, Iwata Takashi, Banno Kouji, Yamagami Wataru, Nishihara Hiroshi, Aoki Daisuke

Abstract excerpt

BACKGROUND: Japan's health insurance covers multigene panel testing. This study aimed to determine the potential availability and utility of gene panel testing clinically in gynecologic oncology. METHODS: We analyzed the characteristics of patients with gynecologic cancer who underwent gene panel testing using FoundationOne® CDx or OncoGuide™ NCC Oncopanel between November 2019 and October 2022. RESULTS: Out of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Endometrial Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genital Neoplasms, Female

Share to Mutation

Share to Ovarian Neoplasms

Share to Sarcoma

Share to Uterine Cervical Neoplasms

Source

Identifiers

PMID: 37574505
DOI: 10.1007/s10147-023-02398-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.PMID 37574505Read ↗

Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancerSemantic proximity Read ↗

Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice.Semantic proximity Read ↗

Clinical Benefit and Agenda for Clinical Sequencing Using Cancer Panel Testing: A Retrospective Clinical StudySemantic proximity Read ↗

Leveraging tumor multigene panel testing to identify germline variants in gynecologic cancers: A retrospective evaluation of an algorithm-based approach.Semantic proximity Read ↗

Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, JapanSemantic proximity Read ↗

Comprehensive genomic profiling for patients with chemotherapy‐naïve advanced cancerSemantic proximity Read ↗

Prognostic impact of genomically matched therapy for solid cancers using real-world data from a provincial hospital in JapanSemantic proximity Read ↗

Real-world clinical utility of comprehensive genomic profiling in advanced solid tumors.Semantic proximity Read ↗

Genomic landscape of endometrial, ovarian and cervical cancers in Japan from database in the Center for Cancer Genomics and Advanced TherapeuticsSemantic proximity Read ↗

Assessment of a cancer genomic profile test for patients with metastatic breast cancer.Semantic proximity Read ↗

Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study.Semantic proximity Read ↗

Clinical Utility of Genomic Profiling Tests in Patients with Advanced Gastrointestinal Cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.